Creative Planning’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Creative Planning’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-13,836	Closed	-$746K	–	2186
2017 Q4	$746K	Buy	13,836 +112	+0.8%	+$6.13K	﹤0.01%	863
2017 Q3	$783K	Buy	13,724 +2,099	+18%	+$123K	﹤0.01%	825
2017 Q2	$699K	Sell	11,625 -420	-3%	-$23.9K	﹤0.01%	849
2017 Q1	$656K	Buy	+12,045	New	+$593K	﹤0.01%	841

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Creative Planning's BIVV Position: Q1 2018 in Review

Creative Planning sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 13,836 shares — an estimated $746K sold.

Creative Planning first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $783K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Creative Planning reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Creative Planning sold 13,836 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $746K.
Creative Planning first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Creative Planning's Bioverativ Inc. Common Stock position peaked at $783K in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Creative Planning's 13F filing for Q1 2018, filed 18 Apr 2018.